Mitochondria dysfunction in the pathogenesis of Alzheimer's disease: Recent advances

W Wang, F Zhao, X Ma, G Perry, X Zhu - Molecular neurodegeneration, 2020 - Springer
Alzheimer's disease (AD) is one of the most prevalent neurodegenerative diseases,
characterized by impaired cognitive function due to progressive loss of neurons in the brain …

Neurobiological highlights of cognitive impairment in psychiatric disorders

A Morozova, Y Zorkina, O Abramova… - International Journal of …, 2022 - mdpi.com
This review is focused on several psychiatric disorders in which cognitive impairment is a
major component of the disease, influencing life quality. There are plenty of data proving that …

TOMM40 Genetic Variants Cause Neuroinflammation in Alzheimer's Disease

YC Chen, SC Chang, YS Lee, WM Ho… - International Journal of …, 2023 - mdpi.com
Translocase of outer mitochondrial membrane 40 (TOMM40) is located in the outer
membrane of mitochondria. TOMM40 is essential for protein import into mitochondria …

[HTML][HTML] The current landscape of prevention trials in dementia

J Lee, RS Howard, LS Schneider - Neurotherapeutics, 2022 - Elsevier
As the prevalence of dementia and Alzheimer's disease (AD) increases worldwide, it is
imperative to reflect on the major clinical trials in the prevention of dementia and the …

Novel Variance-Component TWAS method for studying complex human diseases with applications to Alzheimer's dementia

S Tang, AS Buchman, PL De Jager, DA Bennett… - PLoS …, 2021 - journals.plos.org
Transcriptome-wide association studies (TWAS) have been widely used to integrate
transcriptomic and genetic data to study complex human diseases. Within a test dataset …

The role of opioid receptors in modulating Alzheimer's Disease

P Tanguturi, JM Streicher - Frontiers in Pharmacology, 2023 - frontiersin.org
Alzheimer's disease (AD) is a complex neurological disorder characterized by accumulation
of amyloid plaques and neurofibrillary tangles. Long term investigation of AD pathogenesis …

Discovery of an evodiamine derivative for PI3K/AKT/GSK3β pathway activation and AD pathology improvement in mouse models

S Pang, S Li, H Cheng, Z Luo, X Qi, F Guan… - Frontiers in Molecular …, 2023 - frontiersin.org
Alzheimer's disease (AD) is a neurodegenerative disease characterized by progressive
neurodegeneration and cognitive decline. Evodiamine, a main component in Chinese …

Intrauterine chromium exposure and cognitive developmental delay: The modifying effect of genetic predisposition

Z Jia, H Zhang, Y Lv, L Yu, Y Cui, L Zhang… - Science of The Total …, 2024 - Elsevier
There is limited evidence on the effects of intrauterine chromium (Cr) exposure on children's
cognitive developmental delay (CDD). Further, little is known about the genetic factors in …

[HTML][HTML] Alzheimer's disease cortical morphological phenotypes are associated with TOMM40′ 523-APOE haplotypes

RA Honea, S Hunt, RJ Lepping, ED Vidoni… - Neurobiology of …, 2023 - Elsevier
Both the APOE ε4 and TOMM40 rs10524523 (“523”) genes have been associated with risk
for Alzheimer's disease (AD) and neuroimaging biomarkers of AD. No studies have …

Exploratory analysis of mtDNA haplogroups in two Alzheimer's longitudinal cohorts

RH Swerdlow, D Hui, P Chalise, P Sharma… - Alzheimer's & …, 2020 - Wiley Online Library
Abstract Introduction Inherited mitochondrial DNA (mtDNA) variants may influence
Alzheimer's disease (AD) risk. Methods We sequenced mtDNA from 146 AD and 265 …